Riskpilot← Back to searchSign inGet full accessGLOBAL PHARMA GROUP AS
ASActiveOrg 928006123Bøveien 510, 8470 Bø I VesterålenActivities of call centres · NACE 8220Est. 20215 employees
Revenue 2024
NOK 8,7M
+22% vs 2023
EBITDA margin
-31.6%
+36% vs 2023
Equity ratio
29.5%
Financial strength
Net profit 2024
NOK -3,9M
+5% vs 2023
| Revenue | NOK 8,7M | +22% |
| EBITDA | NOK -2,7M | +36% |
| Net profit | NOK -3,9M | +5% |
| Total assets | NOK 87,3M | +8% |
| Equity | NOK 25,8M | +101% |
| Employees | 5 | — |
Legal name
GLOBAL PHARMA GROUP AS
Org number
928006123
Legal form
Aksjeselskap
NACE code
8220 · Activities of call centres
Founded
27. oktober 2021
Share capital
NOK 3 418 295
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Drift av call senter og logistikk tilknyttet direktehandel samt annen virksomhet som naturlig faller inn under dette, herunder delta i andre selskaper.
Address
Bøveien 510, 8470 Bø I Vesterålen
Phone
+4794972807
Email
kontakt@netthandelskompetanse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 1 738 | 7 102 | 8 688 |
| Staff expenses | −75 | −2 277 | −6 338 | −7 568 |
| EBITDA | −189 | −1 781 | −4 283 | −2 748 |
| Depreciation & amort. | −9 | −68 | −117 | −174 |
| EBIT | −198 | −1 849 | −4 400 | −2 921 |
| Net financials | −60 | −146 | −522 | −2 073 |
| Profit before tax | −258 | −1 994 | −4 922 | −4 995 |
| Tax | −53 | −402 | −803 | −1 079 |
| Net profit | −205 | −1 592 | −4 118 | −3 916 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 10 411 | 18 190 | 80 766 | 87 318 |
| Equity | 4 789 | 11 072 | 12 831 | 25 754 |
| Long-term debt | 0 | 2 000 | 2 000 | 10 000 |
| Short-term debt | 5 622 | 5 118 | 65 935 | 51 564 |
| Total debt | 5 622 | 7 118 | 67 935 | 61 564 |
EBITDA margin
-31.6%
This company
15.8%
Market median
-300% vs market
20212024
Equity ratio
29.5%
This company
38.2%
Market median
-23% vs market
20212024
Return on equity
-15.2%
This company
18.4%
Market median
-183% vs market
20212024
Net profit margin
-45.1%
This company
8.1%
Market median
-657% vs market
20212024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20212024
Debt / equity
2.39×
This company
0.62×
Market median
-285% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TK Chief Executive Officer | Chief Executive Officer | 2024 |
RA Deputy Member | Deputy Member | 2024 |
| Former (2) | ||
HR Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
HH Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Deputy Chairman | 2024 | |
| Former (1) | ||
| Board of Directors | 2024 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 12.87% | 12.87% | 2024 | |
| Company | 11.59% | 11.59% | 2024 | |
| Company | 7.72% | 7.72% | 2024 | |
| Company | 5.15% | 5.15% | 2024 | |
| Company | 3.93% | 3.93% | 2024 | |
| Company | 3.22% | 3.22% | 2024 | |
| Company | 1.95% | 1.95% | 2024 | |
| Company | 1.29% | 1.29% | 2024 | |
| Company | 1.01% | 1.01% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GLOBAL PHARMA GROUP AS 
Helsegruppen AsBoard members of GLOBAL PHARMA GROUP AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Rødsand | Chief Executive Officer | 0 companies |
| Henrik Hallstein Rødsand | Chief Executive Officer | 0 companies |
| Thomas Kristoffer Storvestre | Chief Executive Officer | 0 companies |
| Rikard Arne Storvestre | Deputy Member | 0 companies |
| Svein Erik Nicolaysen | Chairman | 0 companies |
| Terje Andre Skulbru | Board of Directors | 0 companies |
| Per Egil Sørensen | Board of Directors | 0 companies |
| Unn Irene Raknestangen Kjenslie | Deputy Chairman | 0 companies |